Full Text Journal Articles in
Journal J Natl Compr Canc Netw

Advertisement

Find full text journal articles






Improving Interdisciplinary Communication: Barriers and Facilitators for Implementation of Standardized Structured Reporting in Oncology.

Julie E M Swillens, Quirinus J M Voorham, Iris D Nagtegaal, Rosella P M G Hermens,

<h4>Background</h4>Standardized structured reporting (SSR) improves quality of diagnostic cancer reporting and interdisciplinary communication in multidisciplinary team (MDT) meetings, resulting in more adequate treatment decisions and better health outcomes. However, use of SSR varies widely among pathologists, but might be encouraged by MDT members (MDTMs). Our objectives were to identify barriers ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-11]

Cited: 0 times

View full text PDF listing >>



Inherited Mutations in Chinese Men With Prostate Cancer.

Yao Zhu, Yu Wei, Hao Zeng, Yonghong Li, Chi-Fai Ng, Fangjian Zhou, Caiyun He, Guangxi Sun, Yuchao Ni, Peter K F Chiu, Jeremy Y C Teoh, Beihe Wang, Jian Pan, Fangning Wan, Bo Dai, Xiaojian Qin, Guowen Lin, Hualei Gan, Junlong Wu, Dingwei Ye,

<h4>Background</h4>Although China accounts for 7.8% of worldwide new prostate cancer (PCa) cases and 14.5% of new deaths according to GLOBOCAN 2020, the risk of PCa associated with germline mutations is poorly defined, hampered in part by lack of nationwide evidence. Here, we sequenced 19 PCa predisposition genes in 1,836 Chinese ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-9]

Cited: 0 times

View full text PDF listing >>



Advertisement

Association of Social Support With Overall Survival and Healthcare Utilization in Patients With Aggressive Hematologic Malignancies.

P Connor Johnson, Netana H Markovitz, Tamryn F Gray, Sunil Bhatt, Ryan D Nipp, Nneka Ufere, Julia Rice, Matthew J Reynolds, Mitchell W Lavoie, Carlisle E W Topping, Madison A Clay, Charlotta Lindvall, Areej El-Jawahri,

<h4>Background</h4>Social support plays a crucial role for patients with aggressive hematologic malignancies as they navigate their illness course. The aim of this study was to examine associations of social support with overall survival (OS) and healthcare utilization in this population.<h4>Methods</h4>A cross-sectional secondary analysis was conducted using data from a prospective ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-7]

Cited: 0 times

View full text PDF listing >>



Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period.

Aida Bujosa, Consolación Moltó, Thomas J Hwang, José Carlos Tapia, Kerstin N Vokinger, Arnoud J Templeton, Ignasi Gich, Agustí Barnadas, Eitan Amir, Ariadna Tibau,

<h4>Background</h4>Most anticancer drugs are approved by regulatory agencies based on surrogate measures. This article explores the variables associated with overall survival (OS), quality of life (QoL), and substantial clinical benefit among anticancer drugs at the time of approval and in the postmarketing period.<h4>Methods</h4>Anticancer drugs approved by the FDA between January ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-9]

Cited: 0 times

View full text PDF listing >>



Targeting KRAS: Good, But Is It Good Enough?

Margaret Tempero,

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, 19(9):997]

Cited: 0 times

View full text PDF listing >>



PTCH1-GLI1 Fusion-Positive Ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib.

Rofieda R Alwaqfi, Megan I Samuelson, Natalya N Guseva, Michelle Ouyang, Aaron D Bossler, Deqin Ma,

Recurrent GLI1 gene fusions have been recently described in a subset of soft tissue tumors showing a distinct monotonous epithelioid morphology with a rich capillary network and frequent S100 protein expression. Three different fusion partners-ACTB, MALAT1, and PTCH1-have been reported with the PTCH1-GLI1 fusion from 2 patients only, both with ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, 19(9):998-1004]

Cited: 0 times

View full text PDF listing >>



NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.

Efrat Dotan, Louise C Walter, Ilene S Browner, Katherine Clifton, Harvey Jay Cohen, Martine Extermann, Cary Gross, Sumati Gupta, Genevieve Hollis, Joleen Hubbard, Reshma Jagsi, Nancy L Keating, Elizabeth Kessler, Thuy Koll, Beatriz Korc-Grodzicki, June M McKoy, Sumi Misra, Dominic Moon, Tracey O'Connor, Cynthia Owusu, Ashley Rosko, Marcia Russell, Mina Sedrak, Fareeha Siddiqui, Amy Stella, Derek L Stirewalt, Ishwaria M Subbiah, William P Tew, Grant R Williams, Liz Hollinger, Giby V George, Hema Sundar,

The NCCN Guidelines for Older Adult Oncology address specific issues related to the management of cancer in older adults, including screening and comprehensive geriatric assessment (CGA), assessing the risks and benefits of treatment, preventing or decreasing complications from therapy, and managing patients deemed to be at high risk for treatment-related ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, 19(9):1006-1019]

Cited: 0 times

View full text PDF listing >>



NCCN Policy Summit: Innovative Solutions to Drive Down Healthcare Costs: Implications for Access to High-Quality Cancer Care.

Terrell Johnson, Michelle McMurry-Heath, Ted Okon, David Rubin, Robert W Carlson,

The cost of delivering high-quality healthcare in America now consumes 17.7% of the nation's gross domestic product according to Centers for Medicare & Medicaid Services National Health Expenditure Data. With costs threatening to disrupt accessible and equitable care for patients, policymakers are reassessing all matters and functions of the healthcare ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, 19(9):1021-1026]

Cited: 0 times

View full text PDF listing >>



Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Patrick A Brown, Bijal Shah, Anjali Advani, Patricia Aoun, Michael W Boyer, Patrick W Burke, Daniel J DeAngelo, Shira Dinner, Amir T Fathi, Jordan Gauthier, Nitin Jain, Suzanne Kirby, Michaela Liedtke, Mark Litzow, Aaron Logan, Selina Luger, Lori J Maness, Stephanie Massaro, Ryan J Mattison, William May, Olalekan Oluwole, Jae Park, Amanda Przespolewski, Sravanti Rangaraju, Jeffrey E Rubnitz, Geoffrey L Uy, Madhuri Vusirikala, Matthew Wieduwilt, Beth Lynn, Ryan A Berardi, Deborah A Freedman-Cass, Mallory Campbell,

The NCCN Guidelines for Acute Lymphoblastic Leukemia (ALL) focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and adult patients; and supportive care considerations. ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, 19(9):1079-1109]

Cited: 0 times

View full text PDF listing >>



Impact of Nonadherence to NCCN Adjuvant Radiotherapy Initiation Guidelines in Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population.

Anusha Ponduri, David Z Liao, Nicolas F Schlecht, Gregory Rosenblatt, Michael B Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J Ow, Bradley A Schiff, Richard V Smith, Vikas Mehta,

<h4>Background</h4>Nonadherence to NCCN Guidelines during time from surgery to postoperative radiotherapy (S-PORT) can alter survival outcomes in head and neck squamous cell carcinomna (HNSCC). There is a need to validate this impact in an underserved urban population and to understand risk factors and reasons for delay. We sought to investigate ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-7]

Cited: 0 times

View full text PDF listing >>



The Future of Geriatric Oncology Research: Moving Toward Interventions and Objective Biomarkers of Aging.

Efrat Dotan,

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, 19(9):1111-1113]

Cited: 0 times

View full text PDF listing >>



Importance of Family History of Colorectal Carcinoma In Situ Versus Invasive Colorectal Cancer: A Nationwide Cohort Study.

Yu Tian, Elham Kharazmi, Hermann Brenner, Xing Xu, Kristina Sundquist, Jan Sundquist, Mahdi Fallah,

<h4>Background</h4>The aim of this study was to explore the risk of invasive colorectal cancer (CRC) in relatives of patients with colorectal carcinoma in situ (CCIS), which is lacking in the literature.<h4>Patients and methods</h4>We collected data from Swedish family-cancer datasets and calculated standardized incidence ratio (SIR) and cumulative risk of CRC ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-6]

Cited: 0 times

View full text PDF listing >>



Trajectories of Suffering in the Last Year of Life Among Patients With a Solid Metastatic Cancer.

Chetna Malhotra, Rahul Malhotra, Filipinas Bundoc, Irene Teo, Semra Ozdemir, Noreen Chan, Eric Finkelstein,

<h4>Background</h4>Reducing suffering at the end of life is important. Doing so requires a comprehensive understanding of the course of suffering for patients with cancer during their last year of life. This study describes trajectories of psychological, spiritual, physical, and functional suffering in the last year of life among patients with ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-8]

Cited: 0 times

View full text PDF listing >>



Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer.

Camilla Zimmermann, Ashley Pope, Breffni Hannon, Monika K Krzyzanowska, Gary Rodin, Madeline Li, Doris Howell, Jennifer J Knox, Natasha B Leighl, Srikala Sridhar, Amit M Oza, Rebecca Prince, Stephanie Lheureux, Aaron R Hansen, Anne Rydall, Brittany Chow, Leonie Herx, Christopher M Booth, Deborah Dudgeon, Neesha Dhani, Geoffrey Liu, Philippe L Bedard, Jean Mathews, Nadia Swami, Lisa W Le,

<h4>Background</h4>Routine early palliative care (EPC) improves quality of life (QoL) for patients with advanced cancer, but it may not be necessary for all patients. We assessed the feasibility of Symptom screening with Targeted Early Palliative care (STEP) in a phase II trial.<h4>Methods</h4>Patients with advanced cancer were recruited from medical oncology ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-10]

Cited: 0 times

View full text PDF listing >>



Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology Trials.

Brooke E Wilson, Michelle B Nadler, Alexandra Desnoyers, Eitan Amir,

<h4>Background</h4>Censoring due to early drug discontinuation (EDD) or withdrawal of consent or loss to follow-up (WCLFU) can result in postrandomization bias. In oncology, censoring rules vary with no defined standards. In this study, we sought to describe the planned handling and transparency of censoring data in oncology trials supporting FDA ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-8]

Cited: 0 times

View full text PDF listing >>



First- and Second-Line Palliative Systemic Treatment Outcomes in a Real-World Metastatic Pancreatic Cancer Cohort.

Esther N Pijnappel, Willemieke P M Dijksterhuis, Lydia G van der Geest, Judith de Vos-Geelen, Jan Willem B de Groot, Marjolein Y V Homs, Geert-Jan Creemers, Nadia Haj Mohammad, Marc G Besselink, Hanneke W M van Laarhoven, Johanna W Wilmink, ,

<h4>Background</h4>Metastatic pancreatic ductal adenocarcinoma (PDAC) is characterized by a poor survival rate, which can be improved by systemic treatment. Consensus on the most optimal first- and second-line palliative systemic treatment is lacking. The aim of this study was to describe the use of first- and second-line systemic treatment, overall survival ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-8]

Cited: 0 times

View full text PDF listing >>



A Hospital-Wide Intervention to Improve Compliance With TNM Cancer Staging Documentation.

Jason H Lee, Tariq Mohamed, Celia Ramsey, Jihoon Kim, Shelly Kane, Kathryn A Gold, Farhoud Faraji, Joseph A Califano,

<h4>Background</h4>Accurate oncologic staging meeting clinical practice guidelines is essential for guideline adherence, quality assessment, and survival outcomes. However, timely and uniform documentation in the electronic health record (EHR) at the time of diagnosis is a challenge for providers. This quality improvement project aimed to increase provider compliance of timely clinical ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-10]

Cited: 0 times

View full text PDF listing >>



Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms.

Taymeyah Al-Toubah, Eleonora Pelle, Tiffany Valone, Mintallah Haider, Jonathan R Strosberg,

<h4>Background</h4>The capecitabine/temozolomide (CAPTEM) regimen has significant activity in advanced neuroendocrine tumors (NETs). Questions exist regarding activity in pancreatic versus nonpancreatic NETs, risk of opportunistic infections, long-term myelotoxicity, and safety of prolonged treatment duration. Analysis of large patient cohorts is needed for the evaluation of rare toxicities and assessment of risk ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :1-8]

Cited: 0 times

View full text PDF listing >>



BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High-Neutropenia Risk Chemotherapy.

Pamala A Pawloski, Cara L McDermott, James H Marshall, Vanita Pindolia, Catherine M Lockhart, Catherine A Panozzo, Jeffrey S Brown, Bernadette Eichelberger,

<h4>Background</h4>Chemotherapy-induced febrile neutropenia (FN) is prevented or minimized with granulocyte colony-stimulating factors (G-CSFs). Several G-CSF biosimilars are approved in the United States. The Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) is a nonprofit initiative whose objective is to provide scientific evidence on real-world use and comparative safety and effectiveness of ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Local Recurrence and Disease-Free Survival After Transanal Total Mesorectal Excision: Results From the International TaTME Registry.

Sapho X Roodbeen, Marta Penna, Susan van Dieren, Brendan Moran, Paris Tekkis, Pieter J Tanis, Roel Hompes, ,

<h4>Background</h4>The oncologic safety of transanal total mesorectal excision (TaTME) for rectal cancer has recently been questioned, with high local recurrence (LR) rates reported in Dutch and Norwegian experiences. The objective of this study was to evaluate the oncologic safety of TaTME in a large cohort of patients with primary rectal ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.

Marcus J Geer, Charles E Foucar, Sumana Devata, Lydia Benitez, Anthony J Perissinotti, Bernard L Marini, Dale Bixby,

<h4>Background</h4>All-trans retinoic acid (ATRA) serves as the backbone of the management of patients with acute promyelocytic leukemia (APL), with guidelines recommending the initiation of ATRA as soon as APL is suspected. As a regional referral center for patients with acute leukemia, those who are suspected of having APL are often ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta.

Lindsay J Collin, Ming Yan, Renjian Jiang, Keerthi Gogineni, Preeti Subhedar, Kevin C Ward, Jeffrey M Switchenko, Joseph Lipscomb, Jasmine Miller-Kleinhenz, Mylin A Torres, Jolinta Lin, Lauren E McCullough,

<h4>Background</h4>Racial disparities in breast cancer mortality in the United States are well documented. Non-Hispanic Black (NHB) women are more likely to die of their disease than their non-Hispanic White (NHW) counterparts. The disparity is most pronounced among women diagnosed with prognostically favorable tumors, which may result in part from variations ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Mobile Technology-Based (mLearning) Intervention to Enhance Breast Cancer Clinicians' Communication About Sexual Health: A Pilot Trial.

Jennifer Barsky Reese, Lauren A Zimmaro, Sharon L Bober, Kristen Sorice, Elizabeth Handorf, Elaine Wittenberg, Areej El-Jawahri, Mary Catherine Beach, Antonio C Wolff, Mary B Daly, Brynna Izquierdo, Stephen J Lepore,

<h4>Background</h4>Most breast cancer clinicians lack training to counsel patients about sexual concerns. The purpose of this study was to assess the feasibility, acceptability, and preliminary effects of a mobile learning (mLearning) intervention (improving Sexual Health and Augmenting Relationships through Education [iSHARE]) aimed at enhancing breast cancer clinicians' knowledge of, beliefs ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Nonoperative Treatment of Large (5-7 cm), Node-Negative Non-Small Cell Lung Cancer Commonly Deviates From NCCN Guidelines.

Craig S Schneider, Robert A Oster, Aparna Hegde, Michael C Dobelbower, John M Stahl, Adam J Kole,

<h4>Background</h4>Optimal treatment of nonoperative patients with large, node-negative non-small cell lung cancer (NSCLC) is poorly defined. Current NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) recommend definitive radiotherapy (RT) with or without sequential chemotherapy and do not include concurrent chemoradiotherapy (chemoRT) as a treatment option. In this study, we identified ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Impact of Psychological Distress on Treatment Timeliness in Oncology Patients at a Safety-Net Hospital.

Sheshadri Madhusudhana, Michelle Gates, Daulath Singh, Punita Grover, Mahathi Indaram, An-Lin Cheng,

<h4>Background</h4>Psychological distress is common in patients with cancer. Distress can affect patients' engagement with treatment. We examined the relationship between psychological distress and treatment timeliness in a sample of adult oncology patients at a safety-net hospital.<h4>Methods</h4>A retrospective review was conducted of all patients screened for distress at a first outpatient ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

1.0253 s